[unable to retrieve full-text content]
- Retraction: "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" thelancet.com
- COVID-19: WHO Decides To Resume Clinical Trials For Anti-malaria Drug Hydroxychloroquine India Today
- Researchers retract study that found big risks in using hydroxychloroquine to treat covid-19 The Washington Post
- Lancet retracts major Covid-19 paper that raised safety concerns about malaria drugs CNBC
- Study on Safety of Malaria Drugs for Coronavirus Retracted The New York Times
- View Full Coverage on Google News
Health - Latest - Google News
June 05, 2020 at 02:10AM
https://ift.tt/304aaq6
Retraction: "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" - thelancet.com
Health - Latest - Google News
https://ift.tt/2zrj9Ud
No comments:
Post a Comment